CLINICAL TRIALS PROFILE FOR ISTALOL

All Clinical Trials for ISTALOL

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00698945 ↗	Comparison of Istalol™ 0.5% QD (Timolol Maleate/Sorbitol Complex, ISTA Pharmaceutical) to Brimonidine Tartrate 0.1% BID as Adjunctive Therapy to Latanoprost 0.005% in Adults With Ocular Hypertension (OHT) or Open-Angle Glaucoma (OAG)	Completed	Bp Consulting, Inc	Phase 4	2008-06-01	To assess the additional benefit of common adjunctive classes on the diurnal IOP curve in patients assessed as needing additional treatment to reach target intraocular pressure (IOP). To demonstrate superiority of IOP control with Istalol 0.5% QD compared to Brimonidine Tartrate 0.2% BID as adjunctive therapy in adults with uncontrolled IOP's (determined by P.I. based on target pressures) currently treated with Latanoprost 0.05% in the study eye(s).

Clinical Trial Conditions for ISTALOL

Condition Name

Condition Name for ISTALOL
Intervention	Trials
Ocular Hypertension	1
Open-Angle Glaucoma	1

Condition MeSH

Condition MeSH for ISTALOL
Intervention	Trials
Glaucoma, Open-Angle	1
Glaucoma	1
Ocular Hypertension	1
Hypertension	1

Clinical Trial Locations for ISTALOL

Trials by Country

Trials by Country for ISTALOL
Location	Trials
United States	1

Trials by US State

Trials by US State for ISTALOL
Location	Trials
California	1

Clinical Trial Progress for ISTALOL

Clinical Trial Phase

Clinical Trial Phase for ISTALOL
Clinical Trial Phase	Trials
Phase 4	1

Clinical Trial Status

Clinical Trial Status for ISTALOL
Clinical Trial Phase	Trials
Completed	1

Clinical Trial Sponsors for ISTALOL

Sponsor Name

Sponsor Name for ISTALOL
Sponsor	Trials
Bp Consulting, Inc	1

Sponsor Type

Sponsor Type for ISTALOL
Sponsor	Trials
Other	1